News & Media

Events
Interim Report January - September 2020

Read more
Events
HC Wainwright Annual Global Investment Conference

Read more
Events
Interim Report January - June 2020

Read more
Press release
Medivir and SciLifeLab enter collaboration on potential SARS CoV-2 inhibitors

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that it has entered a research collaboration with the Drug Discovery...

Read more
Press release
The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the European Commission, in accordance with the opinion from the...

Read more
Press release
Medivir appoints Yilmaz Mahshid as new CEO

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR) today announced that its Board of Directors has appointed Yilmaz Mahshid as the new...

Read more
Press release
FDA grants MIV-818 Orphan Drug Designation for the treatment of hepatocellular carcinoma

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan...

Read more
Press release
Resolutions at the Annual General Meeting in Medivir on 5 May 2020

Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing director...

Read more
Press release
MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2020

January – March Significant events during the quarter Data from the phase Ia study with MIV-818 in liver cancer patients presented...

Read more
Press release
Medivir receives positive opinion on Orphan Medicinal Drug Designation by the European Medicines Agency for MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that it has received positive opinion from the Committee for Orphan...

Read more
Press release
Medivir announces departure of Chief Medical Officer

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that Linda Basse, Chief Medical Officer at Medivir will leave the company...

Read more
Press release
Medivir 2019 Annual Report published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2019 now is available at the...

Read more